• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/63

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

63 Cards in this Set

  • Front
  • Back
What conditions are most commonly applied to IBD?
Ulcerative colitis
Crohn’s Disease
Epidemiology of IBD
Principally in U.S. and Europe
1 million Americans
- Evenly split between ulcerative colitis and Crohn’s

Highest incidence of onset in ages 15-35
- Also affects those over age 70 and young children
--- 10% under the age of 18

Equal distribution between females and males
Genetic risk factors of IBD
Family history: 20-25% of IBD patients have close relative with IBD
- Brother or sister with IBD=10 x greater risk
White (149/100,000)
African Americans
Hispanics and Asians
American Jews of European descent
4-5 x the prevalence than the general population
Environmental risk factors of IBD
Smoking: 2 x risk
Urban > Rural
Developed world > Underdeveloped world
Northern climates > Southern climates
Etiology of IBD
Unknown

Abnormal mutation or alteration in a gene known as NOD2/CARD15 occurs twice as frequently in Crohn’s patients as the general population.

Environment, antigens, bacteria, viruses, genetics, immune system
What is the difference between ulcerative colitis and Crohn's?
Due to similar symptoms of the diseases, it can be difficult to establish the diagnosis definitively

10% of colitis cases can’t be pinpointed as UC or CD
Ulcerative colitis
Idiopathic inflammatory condition that involves the mucosal surface of the colon.
- Invariably involves the rectum
- May extend proximally in a continuous fashion to involve other portions of the colon
How is ulcerative colitis characterized?
Characterized by periods of symptomatic flare-ups and remissions.
How is ulcerative colitis involvement defined?
Various terms can be used to describe the degree of involvement:
- Ulcerative proctitis (rectum), distal colitis, left sided colitis, extensive colitis, and pancolitis
--- 1/3 proctosigmoiditis, 1/3 left sided colitis, 1/3 extensive colitis
What is the hallmark of ulcerative colitis?
Bloody diarrhea

Always order additional testing to
S/S of mild ulcerative colitis
- Intermittent rectal bleeding associated with the passage of mucus
- Mild diarrhea (less than 4-5 small loose stools/day)
- Left lower quadrant cramps often relieved by defecation
- Fecal urgency or tenesmus
- Periods of constipation common
How is mild ulcerative colitis disease defined?
Typically confined to rectum or rectosigmoid
S/S of moderate ulcerative colitis
Involvement of more than the distal colon, with the inflammatory process extending to at least the splenic flexure.
Frequent loose, bloody stools (up to 10/day)
Mild anemia
Abdominal pain that is not severe
Low grade fever
Hypoalbuminemia (above 3.5 is normal)
How is ulcerative colitis classified?
Variable presentation
Useful to classify by severity of disease
- mild
- moderate
- severe
How is moderate ulcerative colitis disease defined?
Involvement of more than the distal colon, with the inflammatory process extending to at least the splenic flexure.
Fulminant colitis
Subset of severe disease characterized by rapidly worsening symptoms with signs of toxicity.
Toxic megacolon
Results from fulminant colitis.
Condition in which the inflammation extends beyond the mucosa to involve the muscle layers of the colon resulting in impaired colonic mobility, dilated colon, diminished bowel movements, and possible extension to serosa leading to colonic perforation.
How is severe ulcerative colitis disease defined?
Extensive colonic involvement
S/S of toxic megacolon
Very ill patient
Suddenly stops having bowels movements
Possible history of colitis
S/S of severe ulcerative colitis
Frequent loose stools (greater than 10/day)
Abdominal pain and tenderness
Severe anemia often necessitating blood transfusions
Fever
Poor nutritional state with hypoalbuminemia
Signs of hypovolemia: rapid pulse
How is ulcerative colitis diagnosed?
Sigmoidoscopy is diagnostic with acute colitis
Ulcerative colitis imaging
Colonoscopy may be used for disease extent and severity - if no acute flare up
- Risk of perforation with severe disease
- Histological features from biopsy - grade disease activity

Plain abdominal film, supine – severe attack
- Margin of colon is edematous and irregular
- Colon thickening and toxic dilation can be seen

Single-contrast barium enema
- Little utility in acute colitis
- May precipitate toxic megacolon in severe disease
Initial presentation of ulcerative colitis
Gradual onset of symptoms, often preceded by a self-limited episode of rectal bleeding that occurred weeks or months earlier.
Physical examination often normal
- Possible evidence of weight loss, abdominal tenderness, positive fecal occult blood test
How should a normal sigmoid colonic mucosa appear on an endoscopy?
The fine vasculature is easily visible and the surface is shiny and smooth. The folds are of normal thickness.
Abnormal endoscopic imaging
Extensive ulceration of the mucosa is the most common endoscopic finding. The surface is irregular, friable, and erythematous, with loss of normal vascular markings (A). Pseudopolyps may form as a reaction to inflammation (B) and can become quite extensive (C).
Barium enema
Double contrast barium enema demonstrates extensive mucosal ulceration and inflammation throughout the colon.
Differential diagnosis of ulcerative colitis
Exclude other known causes of colitis
Infectious colitis
Stool specimen for:
- Routine bacterial cultures: Salmonella, Shigella, and Campylobacter, E Coli
- Ova and parasites
- Stool toxin assay for C difficile (antibiotics)
Sexually transmitted disease with proctitis
- Gonorrhea, chlamydia, herpes, syphilis
Ischemic (mesenteric) colitis - older patient
Radiation colitis
Crohn’s disease
Complications of UC
Massive hemorrhage: in up to 3% of patients
- May necessitate urgent colectomy
Fulminant colitis: 15% of patients
- 20% of those progress to toxic megacolon with associated risk of perforation and death
Benign stricture
- Surgery indicated for strictures that cause continued symptoms of obstruction
Colon cancer: related to both the duration and extent of the disease
- Colonoscopy recommended every 1-2 years 8 years after diagnosis.
Extraintestinal complications of UC
Uveitis (vision changes) and scleritis
Erythema nodosum and pyoderma gangrenosum
Peripheral arthritis
Ankylosing spondylitis
Lung disease
Venous and arterial thromboembolism
Maintenance of UC
Natural course of the disease consists of intermittent exacerbations alternating with complete symptomatic remission.
Very small percentage of patients never achieve relapse.
75% of patients who go into remission will experience a symptomatic relapse within 1 year without long-term medical therapy.
Relapse rates reduced to 35% with long-term maintenance therapy.

Sulfasalazine 1-1.5 g bid, mesalamine 800 mg 2-3 times daily or 500 mg qid
What is the curative treatment of UC?
Surgical resection
Prognosis of UC
Lifelong disease
- Characterized by exacerbations and remissions
Most never require surgery or hospitalization
Surgery is curative
With management, majority of patients lead close to normal productive lives
Crohn's disease
Characterized by transmural inflammation of the gastrointestinal tract.

As opposed to the mucosal lining of UC.
What areas of the GI tract may be involved with Crohn's?
May involve the entire GI tract from mouth to anus
50% small bowel involvement only
50% ileocolitis: involvement of both ileum and colon
20% disease limited to the colon
- ½ have sparing of the rectum (as opposed to UC)
Small percentage have predominant involvement of the mouth or upper GI
1/3 perianal disease
What is the main difference in areas that are affected by UC and Crohn's?
½ of Crohn's patients have sparing of the rectum (distinguishes from UC)
Pathophysiology of Crohn's
Transmural inflammation often leads to fibrosis and to obstructive clinical presentations not typically seen in ulcerative colitis.
S/S of Crohn's
Presentation varies depending on extent of disease
Most common
- Low-grade fever, malaise, weight loss, decreased energy
- Ileitis or ileocolitis: diarrhea, typically non-bloody
Colitis: may be bloody diarrhea and fecal urgency
Physical exam findings of Crohn's
Focal tenderness in right lower quadrant
Palpable tender mass representing inflamed intestine.
Intestinal obstructions related to Crohn's
Narrowing of the small bowel
Results from inflammation, spasm, or fibrotic stenosis.

Patients present with postprandial bloating, cramping, and borborygmi.
Sinus tracts related to Crohn's
Penetrate through the bowel and may be contained or form fistulas
- Mass palpable on PE with fever and pain
Fistulas related to Crohn's
Connects (opens up) to epithelial lined organs
Ileocecal fistulae common
Perianal disease related to Crohn's
1/3 of patients
Skin tags, anal fissures, abscesses, and fistulas
Extraintestinal Crohn's disease
Arthralgias, arthritis, uveitis, aphthous ulcers (canker sores), gallstones, nephrolithiasis
Lab findings of Crohn's
CBC
- Anemia may reflect mucosal blood loss, chronic inflammation, iron deficiency, vitamin B12 malabsorption
- Leukocytosis may reflect inflammation, abscess formation, corticosteroid therapy
Hypoalbuminemia
Elevated sed rate or C-reactive protein
Stool specimens
What is the dominant feature of Crohn's?
Ulcers are the dominant endoscopic feature
Linear and discontinuous - “skip lesions”

Early changes may be patchy erythema or aphthoid ulcers (resembles canker sores).
Barium enema findings of Crohn's
“Cobblestone” on barium enema
- Diffuse thickening of the small bowel mucosa in a patient with Crohn’s .
- Cobblestone appearance is produced by barium being dispersed between the edematous inflamed mucosa
CT findings of Crohn's
Useful in identifying ulcerations, fistulas, and strictures
Bowel wall thickening
Barium upper GI series with small bowel follow-through.
Complications of Crohn's
Abscess
- Tender abdominal mass, fever, leukocytosis
- Emergent CT
- Surgery needed to clear abscess
Obstruction
- IV fluids with NG suction
Fistulas
- Frequently require surgical therapy
Colon carcinoma: routine colonoscopy
How should the diet of an urgent Crohn's patient be managed?
Always have patient NPO immediately
Prognosis
Lifelong illness that can have profound emotional and social impacts.
Few die as result.
Most cope with disease and complications.
Can lead productive lives.
5-ASA treatment of Crohn's
5-Aminosalicylic Acid (5-ASA): Potent anti-inflammatory effects
Used for active treatment and during disease inactivity to maintain remission
- Mesalamine
---Topical form in suppositories and enemas (UC)
--- used for disease in distal colon
- Azo compounds: sulfasalazine, balsalazide
- must supplement with folate
Corticosteroid treatment of Crohn's
Induce remission in patients unresponsive to 5-ASA agents.
Short-term utility
Side effects with short-term use
- mood changes, insomnia, dyspepsia, weight gain, edema, elevated serum glucose, acne
Corticosteroid treatment of Crohn's
Corticosteroid dependent patients in an attempt to maintain remission upon withdrawal of corticosteroid
Mercaptopurine and azathioprine: immunosuppressant of leukocytes
Inhibits the immune response and allows 2/3 of UC and CD pts to wean from corticosteroids
Cyclosporine
Potent immune suppressant used in transplant patients
Alters immune response by inhibiting T cell responses
Helps maintain remission with azathioprine and mercaptopurine
Methotrexate:
- Potent anti-folate drug, used for CA tx, 2˚ effect on immune system
- Effectively induces remission and reduces glucocorticoid dosage
Side effects of long-term corticosteroid use
Potentially serious side effects with long-term use

Effects can be seen when patient uses steroid for more than 3 months cumulatively over lifetime.
- osteoporosis, osteonecrosis of the femoral head, myopathy, cataracts, susceptibility to infections
Biologic therapies
Narrowly target various components of the immune system.
Highly effective for patients with corticosteroid-dependent or refractory disease.
- High cost, potentially life-threatening side effects
Anti-TNF Therapies
- Infliximab, adalimumab, and certolizumab
Side effects: antibody development, urticaria, diaphoresis, chest tightness, serious infections
Anitbiotics
Used after surgery to treat complications of UC surgery
Used with active inflammatory, fistulous, and perianal CD, and may prevent recurrence after surgery
Nutritional therapies
Bowel rest and TPN can induce remission of active CD but does not maintain well – has complications.

Not as effective for UC.
Treatment of distal colitis
Drug of choice: topical mesalamine
1000 mg suppository once daily at bedtime
4 g enema
Topical corticosteroids and oral 5-ASA second choice
Treatment of mild-moderate colitis
5-ASA, Corticosteroids, Immunomodulating agents
Treatment of severe colitis
Hospitalization
- Due to risk of toxic megacolon or fulminant colitis
D/C oral intake 24-48 hrs.
IV Corticosteroids
- Anti-TNF infusion or cyclosporine if no improvement in a week
Surgery
- If 7-10 days of IV pharmacotherapy fails.
Surgery for UC
Nearly ½ of pts undergo surgery within the first 10 years of illness
Morbidity is 20% elective, 30% urgent, 40% emergent
Risks: hemorrhage, contamination, sepsis
Surgery for Crohn's
Most pts require at least one operation in their lifetime
Need for surgery related to duration of disease and site of involvement
Small bowel disease - 80% chance of requiring surgery
Colon disease – 50% chance of requiring surgery
Key differences between UC and colitis
Ulcerative Colitis
- Colon only
- Mucosal layer
- Continuous lesions
- More association with rectal bleeding

Crohn’s Disease
- Can include entire GI (mouth to anus)
- Transmural
- Patchy “skips”
- Perianal disease